Get started
Author

Patrick Younan

Observed institution: Seagen (United States)
ORCID: 0000-0001-6805-5815
Observed ORCID: 0000-0001-6805-5815
OpenAlex ID: A5014192055
Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2023 · Ryan A. Heiser, Anthony T. Cao, et al. · Molecular Cancer Therapeutics · 82
PDF
1187 Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors
2022 · Devra Olson, Patrick Younan, et al. · Journal for ImmunoTherapy of Cancer · 16
PDF
Abstract 1522: SGN-B6A induces immunogenic cell death as an additional mechanism of action
2023 · Vivian H. Trang, Rebecca C. Mazahreh, et al. · Cancer Research · 3
Enfortumab vedotin induces immunogenic cell death and shows enhanced preclinical antitumor activity when combined with a PD-1 inhibitor
2026 · Devra J. Olson, Bernard A. Liu, et al. · Cell Reports Medicine · 1
PDF
Table S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al. · 1
Figure S6 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Table S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S4 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S6 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Figure S5 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S4 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S2 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Figure S2 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S3 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Supplementary Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Figure S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Figure S5 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
Supplementary Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
2024 · Ryan A. Heiser, Anthony T. Cao, et al.
PDF
472 Knockdown of VISTA protein using antisense oligonucleotides promotes superior anti-tumor immunity compared to antibody blockade
2022 · Brittany Morrow, Michael Curran, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 21
Citation count: 103
H-index: 3
I10-index: 2
Year
Topic
Type